ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesG12.21

G12.21

Billable

Amyotrophic lateral sclerosis

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 G12.21 is a billable code used to indicate a diagnosis of amyotrophic lateral sclerosis.

Key Diagnostic Point:

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects motor neurons in the brain and spinal cord. The condition leads to the degeneration and death of these neurons, resulting in muscle weakness, atrophy, and eventual paralysis. Patients typically present with symptoms such as muscle twitching, cramping, and difficulty with speech, swallowing, and breathing. The onset of ALS is usually insidious, with symptoms gradually worsening over time. While the exact cause of ALS remains unclear, both genetic and environmental factors are believed to play a role. Approximately 5-10% of cases are familial, linked to specific genetic mutations, while the majority are sporadic. The disease is characterized by the absence of sensory involvement, meaning that patients retain their cognitive function and sensory perception until late stages. Diagnosis is primarily clinical, supported by electromyography (EMG) and neuroimaging to rule out other conditions. Management focuses on symptomatic relief and supportive care, as there is currently no cure for ALS.

Code Complexity Analysis

Complexity Rating: High

High Complexity

Complexity Factors

  • Variability in symptom presentation and progression among patients
  • Need for comprehensive documentation to support diagnosis
  • Potential overlap with other motor neuron diseases
  • Genetic testing implications for familial cases

Audit Risk Factors

  • Inadequate documentation of symptom progression
  • Failure to document multidisciplinary care
  • Misdiagnosis or coding of related conditions
  • Lack of genetic testing documentation in familial cases

Specialty Focus

Medical Specialties

Neurology

Documentation Requirements

Detailed clinical notes on symptom onset, progression, and neurological examination findings.

Common Clinical Scenarios

Initial diagnosis of ALS, management of symptoms, and coordination of care with other specialists.

Billing Considerations

Ensure documentation reflects the multidisciplinary approach, including physical therapy and respiratory support.

Genetics

Documentation Requirements

Genetic testing results and family history documentation.

Common Clinical Scenarios

Evaluation of patients with a family history of ALS for genetic counseling and testing.

Billing Considerations

Document the rationale for genetic testing and the implications for family members.

Coding Guidelines

Inclusion Criteria

Use G12.21 When
  • Follow official coding guidelines for neurodegenerative diseases, ensuring accurate documentation of clinical findings and symptomatology
  • Include details on the progression of the disease and any associated conditions

Exclusion Criteria

Do NOT use G12.21 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

95860CPT Code

Electromyography, needle

Clinical Scenario

Used to confirm diagnosis of ALS through assessment of motor neuron function.

Documentation Requirements

Document the rationale for EMG and findings that support ALS diagnosis.

Specialty Considerations

Neurologists should ensure that EMG findings are clearly linked to clinical symptoms.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of ALS, improving the accuracy of data collection and reimbursement processes. It has also facilitated better tracking of the disease's prevalence and management outcomes.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of ALS, improving the accuracy of data collection and reimbursement processes. It has also facilitated better tracking of the disease's prevalence and management outcomes.

Reimbursement & Billing Impact

reimbursement processes. It has also facilitated better tracking of the disease's prevalence and management outcomes.

Resources

Clinical References

  • •
    ALS Association

Coding & Billing References

  • •
    ALS Association

Frequently Asked Questions

What is the primary difference between ALS and other motor neuron diseases?

ALS is characterized by both upper and lower motor neuron involvement, while other motor neuron diseases may present with only one type of motor neuron degeneration.